Shanghai, China – 13 November, 2014 - PROFEMUR® Classic Z Hip Stem, a hip device developed by MicroPort Orthopedics, was recently awarded registration certificate from China Food and Drug Administration ("CFDA").
The device is designed to cure hip pain and hip functional disabilities caused by hip diseases such as osteoarthritis, rheumatic arthritis and femoral neck fracture. PROFEMUR® Classic Z Hip Stem shares the same design concept with PROFEMUR® Z modular stem which was first launched in 1985 and has been proved safe and effective with its over 29 years' excellent clinical history.
The PROFEMUR® Classic Z Hip Stem is a dual tapered, titanium-alloy hip implant with a rectangular cross-section. The tapered, rectangular cross-section provides proximal fixation and rotational stability. With two neck angels in two lengths, the product offers surgeons a variety of options to meet range of anatomical needs.
"The product is currently sold in many countries across the globe, and now with the CFDA registration certificate, we have high expectations on its sales performance in the China market," said Simon Chen, Vice General Manager of Marketing of Shanghai MicroPort Orthopedics Co.